Pharmacotherapy

(6)
Pharmacotherapy image
ISBN-10:

0071416137

ISBN-13:

9780071416139

Edition: 6
Released: May 12, 2005
Format: Hardcover, 2802 pages

Description:

The gold standard text for the therapeutics course mandatory in pharmacy schools. Now in its sixth edition, this classic text continues its long-standing tradition of offering unparalleled guidance in the development of pharmaceutical care plans. The book provides a unique process of thinking about pharmacotherapy the process which uses evidence-based approaches to the drug treatment of diseases.

Features:
*FREE Online Resource Center for professors and students - study materials, web chapters, questions and answers, and updates
*NEW Key Concepts begin each chapter
*Excellent use of algorithms, tables, and charts – provides clear recommendations
*“Clinical Controversies” in the treatment sections of disease-oriented chapters

Best prices to buy, sell, or rent ISBN 9780071416139




Related Books

Frequently Asked Questions about Pharmacotherapy

You can buy the Pharmacotherapy book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $9.93 on Amazon and is available from 16 sellers at the moment.

At BookScouter, the prices for the book start at $5.48. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.

If you’re interested in selling back the Pharmacotherapy book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Pharmacotherapy book, the best buyback offer comes from and is $ for the book in good condition.

The Pharmacotherapy book is in very low demand now as the rank for the book is 5,550,762 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.